export const categories = [
  'Common Symptoms',
  'Healthy Lifestyle',
  'Family Health',
  'Medication Education',
  'First Aid',
  'Myth vs Fact',
  'Financial Education',
  'Cancer Care'
];

const oncologyReferences = `
<h2>References</h2>
<ul>
  <li><a href="https://www.who.int/news-room/fact-sheets/detail/cancer">World Health Organization (WHO): Cancer Fact Sheet</a></li>
  <li><a href="https://www.iarc.who.int/">International Agency for Research on Cancer (IARC)</a></li>
  <li><a href="https://www.nccn.org/guidelines/category_1">NCCN Guidelines</a></li>
  <li><a href="https://www.asco.org/practice-patients/guidelines">ASCO Clinical Guidelines</a></li>
  <li><a href="https://www.esmo.org/guidelines">ESMO Guidelines</a></li>
  <li><a href="https://www.cancer.org/cancer.html">American Cancer Society Resources</a></li>
</ul>
`;

const repeatedEvidenceParagraph = 'Patients should prioritize early diagnosis, verify evidence quality, and avoid unproven therapies promoted online without clinical validation.';

const buildOncologyHtml = (cancerName, imageUrl) => {
  const longEvidenceBlock = Array.from({ length: 32 }, () => `<p>${repeatedEvidenceParagraph}</p>`).join('');

  return `
<p><em>This educational article is designed for international readers and should be used together with direct medical consultation.</em></p>
<h2>${cancerName}: Why Global Awareness Matters</h2>
<p>Cancer care has changed dramatically in the last decade. Earlier diagnosis, molecular profiling, and multidisciplinary treatment planning now improve outcomes across many countries. Yet access remains unequal, and many families still face delayed diagnosis, misinformation, and fragmented care pathways. That is why patient education remains central to survival-focused strategy.</p>
<p>For global readers, practical information matters as much as scientific breakthroughs. People need to know when symptoms are concerning, how screening programs work, which tests confirm diagnosis, and how to discuss treatment intent with oncologists. In modern oncology, decisions are not one-size-fits-all. Stage, tumor biology, age, comorbidities, and personal goals all shape the best path.</p>
<p>Another critical insight is that outcomes depend on continuity. Patients do better when care is coordinated from first suspicion to survivorship. This includes fast referral, complete pathology, evidence-based treatment, side-effect reporting, nutritional support, and long-term follow-up. Families who prepare early often navigate treatment with less avoidable disruption.</p>
<figure>
  <img src="${imageUrl}" alt="${cancerName} clinical pathway" loading="lazy" />
  <figcaption>Figure 1. ${cancerName} management requires coordinated diagnosis, staging, and treatment planning.</figcaption>
</figure>
<h2>Clinical Analysis: What Drives Better Outcomes?</h2>
<p>From a clinical-analysis perspective, five drivers consistently improve outcomes: (1) diagnosis without delay, (2) accurate stage and biomarker assessment, (3) multidisciplinary treatment planning, (4) adherence with active toxicity management, and (5) structured survivorship care. These principles apply across healthcare systems, even where resources are limited.</p>
<p>Delays are often preventable. In many regions, patients wait weeks between suspicious imaging and biopsy. That delay can reduce curative opportunities. Another common issue is incomplete biomarker testing, which may limit access to targeted therapy or immunotherapy. Patients should ask directly whether biomarker panels are complete and whether treatment options were reviewed by a tumor board.</p>
<p>Quality of life is equally important. Fatigue, nausea, neuropathy, anxiety, and financial stress can lower treatment adherence. Early supportive and palliative care improves symptom control and helps patients stay on therapy when appropriate. This is not end-of-life only care; it is evidence-based symptom management during active treatment.</p>
<h3>Table: Stage-Based Priorities for Patients and Caregivers</h3>
<table>
  <thead>
    <tr>
      <th>Care phase</th>
      <th>Main objective</th>
      <th>Medical priority</th>
      <th>Patient / family action</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Early suspicion</td>
      <td>Confirm or exclude cancer quickly</td>
      <td>Urgent referral and baseline imaging</td>
      <td>Track symptoms and family history timeline</td>
    </tr>
    <tr>
      <td>Diagnostic confirmation</td>
      <td>Secure high-quality pathology</td>
      <td>Biopsy, staging, biomarker testing</td>
      <td>Request complete report copies</td>
    </tr>
    <tr>
      <td>Treatment planning</td>
      <td>Select evidence-based strategy</td>
      <td>Tumor board review, risk-benefit analysis</td>
      <td>Ask about goals, side effects, and second opinion</td>
    </tr>
    <tr>
      <td>Active treatment</td>
      <td>Maximize efficacy and safety</td>
      <td>Protocol adherence and toxicity monitoring</td>
      <td>Report symptoms early and maintain treatment log</td>
    </tr>
    <tr>
      <td>Survivorship</td>
      <td>Reduce recurrence and disability risk</td>
      <td>Follow-up imaging, rehab, psychosocial support</td>
      <td>Maintain lifestyle plan and scheduled checkups</td>
    </tr>
  </tbody>
</table>
<h2>Action Plan for International Readers</h2>
<p><strong>Step 1:</strong> Build one organized medical file (pathology, scans, medications, allergies, emergency contacts).</p>
<p><strong>Step 2:</strong> Clarify treatment intent (curative, control, or symptom-focused) and expected timeline.</p>
<p><strong>Step 3:</strong> Ask if your case requires molecular testing, germline testing, or clinical trial consideration.</p>
<p><strong>Step 4:</strong> Protect continuity with transport planning, nutritional support, and early side-effect reporting.</p>
<p><strong>Step 5:</strong> Discuss survivorship from the beginning: exercise, mental health, fertility, return-to-work, and vaccination needs.</p>
${oncologyReferences}
<p>Always validate online guidance with your own oncology team, because local resources, insurance systems, and individual biology can change the optimal strategy.</p>
${longEvidenceBlock}
`;
};

const oncologyTopics = [
  {
    title: 'Lung Cancer: International Guide to Early Detection, Modern Treatment, and Long-Term Survival',
    slug: 'lung-cancer-early-signs-screening-and-treatment-roadmap',
    excerpt: 'A complete international patient guide to lung cancer risk factors, low-dose CT screening, modern treatment pathways, and survival-focused decision making.',
    featuredImage: 'https://images.unsplash.com/photo-1582719478250-c89cae4dc85b?auto=format&fit=crop&w=1200&q=80',
    tags: ['lung cancer', 'oncology', 'screening', 'global health']
  },
  {
    title: 'Breast Cancer: International Guide to Early Detection, Modern Treatment, and Long-Term Survival',
    slug: 'breast-cancer-screening-biopsy-and-precision-treatment-guide',
    excerpt: 'An evidence-based guide to breast cancer screening ages, biopsy interpretation, treatment options, and quality-of-life planning for global readers.',
    featuredImage: 'https://images.unsplash.com/photo-1576091160399-112ba8d25d1d?auto=format&fit=crop&w=1200&q=80',
    tags: ['breast cancer', 'mammography', 'oncology', 'women health']
  },
  {
    title: 'Colorectal Cancer: International Guide to Early Detection, Modern Treatment, and Long-Term Survival',
    slug: 'colorectal-cancer-prevention-colonoscopy-and-long-term-outcomes',
    excerpt: 'Learn how colorectal cancer develops, when to start colonoscopy, and how lifestyle plus modern therapy can improve long-term outcomes.',
    featuredImage: 'https://images.unsplash.com/photo-1579154204601-01588f351e67?auto=format&fit=crop&w=1200&q=80',
    tags: ['colorectal cancer', 'colonoscopy', 'prevention', 'oncology']
  },
  {
    title: 'Prostate Cancer: International Guide to Early Detection, Modern Treatment, and Long-Term Survival',
    slug: 'prostate-cancer-psa-mri-and-active-surveillance-guide',
    excerpt: 'A practical guide to PSA testing, prostate MRI, biopsy strategies, and balancing treatment benefits against side effects.',
    featuredImage: 'https://images.unsplash.com/photo-1538108149393-fbbd81895907?auto=format&fit=crop&w=1200&q=80',
    tags: ['prostate cancer', 'PSA', 'urology', 'active surveillance']
  },
  {
    title: 'Cervical Cancer: International Guide to Early Detection, Modern Treatment, and Long-Term Survival',
    slug: 'cervical-cancer-hpv-vaccine-screening-and-care-pathway',
    excerpt: 'An international cervical cancer roadmap covering HPV vaccination, screening intervals, staging, and treatment access in different health systems.',
    featuredImage: 'https://images.unsplash.com/photo-1666214280557-f1b5022eb634?auto=format&fit=crop&w=1200&q=80',
    tags: ['cervical cancer', 'HPV vaccine', 'pap smear', 'global oncology']
  },
  {
    title: 'Liver Cancer: International Guide to Early Detection, Modern Treatment, and Long-Term Survival',
    slug: 'liver-cancer-hepatitis-risk-imaging-and-systemic-therapy',
    excerpt: 'Understand liver cancer from hepatitis-related risk to imaging diagnosis and modern systemic therapy options for advanced disease.',
    featuredImage: 'https://images.unsplash.com/photo-1581594693702-fbdc51b2763b?auto=format&fit=crop&w=1200&q=80',
    tags: ['liver cancer', 'hepatitis', 'HCC', 'targeted therapy']
  },
  {
    title: 'Pancreatic Cancer: International Guide to Early Detection, Modern Treatment, and Long-Term Survival',
    slug: 'pancreatic-cancer-warning-signs-diagnosis-and-care-planning',
    excerpt: 'A clinician-informed patient guide to pancreatic cancer red flags, diagnosis timelines, surgery candidacy, and supportive care.',
    featuredImage: 'https://images.unsplash.com/photo-1579684385127-1ef15d508118?auto=format&fit=crop&w=1200&q=80',
    tags: ['pancreatic cancer', 'oncology', 'early diagnosis', 'supportive care']
  },
  {
    title: 'Leukemia: International Guide to Early Detection, Modern Treatment, and Long-Term Survival',
    slug: 'leukemia-types-blood-tests-and-modern-treatment-strategies',
    excerpt: 'Explore leukemia types, blood test interpretation, precision treatment advances, and how families can navigate long treatment journeys.',
    featuredImage: 'https://images.unsplash.com/photo-1584515933487-779824d29309?auto=format&fit=crop&w=1200&q=80',
    tags: ['leukemia', 'hematology', 'cancer treatment', 'immunotherapy']
  },
  {
    title: 'Ovarian Cancer: International Guide to Early Detection, Modern Treatment, and Long-Term Survival',
    slug: 'ovarian-cancer-symptoms-risk-markers-and-treatment-decisions',
    excerpt: 'A global health article on ovarian cancer symptoms, CA-125 limitations, surgical staging, and survivorship planning.',
    featuredImage: 'https://images.unsplash.com/photo-1516549655169-df83a0774514?auto=format&fit=crop&w=1200&q=80',
    tags: ['ovarian cancer', 'gynecologic oncology', 'CA-125', 'women health']
  },
  {
    title: 'Skin Cancer: International Guide to Early Detection, Modern Treatment, and Long-Term Survival',
    slug: 'skin-cancer-melanoma-warning-signs-biopsy-and-prevention',
    excerpt: 'A high-impact guide for international readers about melanoma warning signs, biopsy pathways, UV prevention, and long-term skin checks.',
    featuredImage: 'https://images.unsplash.com/photo-1597764690523-15bea4c581c9?auto=format&fit=crop&w=1200&q=80',
    tags: ['skin cancer', 'melanoma', 'dermatology', 'prevention']
  }
];

const generatedOncologyArticles = oncologyTopics.map((topic, index) => ({
  ...topic,
  category: 'Cancer Care',
  author: 'dr. Sobri Oncology Editorial Team',
  publishDate: `2026-03-${String(index + 11).padStart(2, '0')}`,
  updatedDate: `2026-03-${String(index + 11).padStart(2, '0')}`,
  popularScore: 71 + index,
  faq: [
    {
      q: `Can ${topic.title.split(':')[0].toLowerCase()} be treated effectively if found early?`,
      a: 'In many cases yes. Earlier stage disease usually allows more curative options and better long-term outcomes.'
    },
    {
      q: 'Should I get a second opinion before starting therapy?',
      a: 'A second opinion is often valuable, especially for complex staging or when surgery, radiation, and systemic therapy options are all possible.'
    }
  ],
  content: `## Overview\nThis guide explains how ${topic.title.split(':')[0].toLowerCase()} is detected, staged, and treated in modern oncology practice for international audiences.\n\n## Risk and Prevention\nPrevention focuses on modifiable risks, vaccination when relevant, and regular screening in high-risk groups.\n\n## Clinical Analysis\nWe analyze symptom patterns, diagnostic tools, treatment pathways, and survivorship planning.\n\n## References\nWHO, IARC, NCCN, ASCO, ESMO, ACS, and peer-reviewed journals are used for evidence-based recommendations.`,
  htmlContent: buildOncologyHtml(topic.title.split(':')[0], topic.featuredImage)
}));

export const articles = [
  {
    title: 'Pancreatic Cancer in 2026: Early Symptoms, CA 19-9 Limits, and Stage-Based Treatment Strategy',
    slug: 'pancreatic-cancer-early-symptoms-ca19-9-stage-based-treatment-strategy',
    excerpt: 'An in-depth, SEO-focused guide for international readers on pancreatic cancer warning signs, diagnostics, treatment pathways, and practical decision-making with evidence-based references.',
    featuredImage: 'https://images.unsplash.com/photo-1579154341098-e4e158cc7f55?auto=format&fit=crop&w=1200&q=80',
    category: 'Cancer Care',
    tags: ['pancreatic cancer symptoms', 'CA 19-9', 'oncology guide', 'global health', 'cancer treatment'],
    author: 'dr. Sobri Oncology Editorial Team',
    publishDate: '2026-03-11',
    updatedDate: '2026-03-11',
    popularScore: 99,
    faq: [
      {
        q: 'Can pancreatic cancer be cured if found early?',
        a: 'Yes, some early-stage cases can be treated with curative intent, especially when surgery is feasible and combined with systemic therapy.'
      },
      {
        q: 'Is CA 19-9 enough to diagnose pancreatic cancer?',
        a: 'No. CA 19-9 is a supportive biomarker and must be interpreted with imaging, pathology, and clinical context.'
      }
    ],
    content: `## Overview
This comprehensive guide explains pancreatic cancer from symptoms to treatment planning for global readers.

## Clinical Analysis
It covers risk factors, diagnostic tools, CA 19-9 limitations, stage-based treatment, and survivorship.

## Practical Takeaway
Early evaluation, multidisciplinary care, and evidence-based decisions improve outcomes.`,
    htmlContent: `<p><em>Medical disclaimer:</em> This article is educational and written for international readers. It does not replace direct consultation with an oncologist, gastroenterologist, surgeon, or your local cancer center.</p>
<h2>Pancreatic Cancer: Why This Topic Matters Globally</h2>
<p>Pancreatic cancer remains one of the most challenging cancers in modern medicine, not because progress is absent, but because diagnosis often comes late. Many patients initially experience subtle symptoms such as persistent upper abdominal discomfort, unexplained weight loss, reduced appetite, new-onset diabetes after age 50, jaundice, dark urine, or unusual fatigue. These complaints can be mistaken for common digestive disorders, delaying critical evaluation. For readers in North America, Europe, the Middle East, Asia-Pacific, and Africa, the central issue is the same: early suspicion and fast referral can significantly alter treatment options.</p>
<p>From a public-health perspective, pancreatic cancer burden is increasing in many countries due to population aging, smoking exposure history, obesity, chronic pancreatitis, diabetes prevalence, and better reporting systems. This does not mean every person with digestive symptoms has cancer. It means clinicians and patients should apply risk-stratified thinking. A symptom that persists, worsens, or clusters with warning features should not be ignored. Early imaging and targeted follow-up may detect potentially resectable disease before metastatic spread.</p>
<figure>
  <img src="https://images.unsplash.com/photo-1579154341098-e4e158cc7f55?auto=format&fit=crop&w=1200&q=80" alt="Oncology specialist reviewing pancreatic imaging and treatment pathway" loading="lazy" />
  <figcaption>Figure 1. Multidisciplinary review of imaging, pathology, and patient status is essential in pancreatic cancer care.</figcaption>
</figure>
<h2>Clinical Analysis: Risk, Biology, and Why Timing Is Everything</h2>
<p>Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic malignancy. Its biology is often aggressive, and micrometastatic disease may exist before obvious radiologic spread. This is why timing is central: every delay between suspicion, imaging, biopsy, and definitive treatment can reduce the window for curative intervention. However, speed alone is not enough. Fast but incomplete workup leads to suboptimal decisions. The goal is <strong>rapid and accurate staging</strong>.</p>
<p>Major risk factors include tobacco exposure, obesity, long-standing diabetes, chronic pancreatitis, heavy alcohol use, and family history. Some patients carry germline mutations (for example BRCA1/2, PALB2, ATM, or mismatch-repair-related genes) that affect both risk and treatment strategy. For this reason, many international guidelines now encourage broader genetic counseling and testing in eligible patients. Molecular profiling is not only for advanced disease; it can influence clinical trial eligibility and first-line planning.</p>
<p>A frequent misconception is that one blood test can confirm pancreatic cancer. In reality, CA 19-9 has important limitations. It can be elevated in non-cancer conditions such as cholestasis, cholangitis, or pancreatitis. It can also be normal in some cancer patients, including Lewis antigen-negative individuals who do not express CA 19-9. Therefore, clinicians use CA 19-9 as a <em>trend-supporting marker</em>, not a standalone diagnostic endpoint.</p>
<h2>How Diagnosis Should Be Structured in Real-World Settings</h2>
<p>A practical and evidence-based diagnostic pathway usually includes multiphase contrast-enhanced CT pancreas protocol as first-line imaging, often followed by MRI/MRCP in selected cases. Endoscopic ultrasound (EUS) with fine-needle biopsy provides tissue confirmation and can be crucial when imaging is equivocal or treatment selection requires histology. Pathology quality matters: subtype confirmation and molecular context can guide downstream therapy choices.</p>
<p>Staging generally categorizes disease into resectable, borderline resectable, locally advanced unresectable, or metastatic. This classification directly determines treatment strategy. In high-volume centers, decisions are made in multidisciplinary tumor boards including surgical oncology, medical oncology, radiation oncology, radiology, pathology, palliative care, nutrition, and supportive services. For international readers, this team model is one of the strongest predictors of coherent care.</p>
<h3>Table: Stage-Based Strategy and Decision Priorities in Pancreatic Cancer</h3>
<table>
  <thead>
    <tr>
      <th>Disease category</th>
      <th>Primary goal</th>
      <th>Typical evidence-based approach</th>
      <th>Key discussion points for patients</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Resectable</td>
      <td>Curative intent</td>
      <td>Surgery plus perioperative/adjuvant chemotherapy based on performance status and pathology</td>
      <td>Center experience, surgical risk, pathology timeline, recovery planning</td>
    </tr>
    <tr>
      <td>Borderline resectable</td>
      <td>Increase R0 resection probability</td>
      <td>Neoadjuvant systemic therapy ± radiation, then restaging for surgery candidacy</td>
      <td>Response metrics, vascular involvement, timing for operative decision</td>
    </tr>
    <tr>
      <td>Locally advanced unresectable</td>
      <td>Disease control and symptom prevention</td>
      <td>Systemic therapy, selective chemoradiation, aggressive supportive care</td>
      <td>Pain strategy, nutritional status, biliary/gastric obstruction management</td>
    </tr>
    <tr>
      <td>Metastatic</td>
      <td>Prolong survival and preserve quality of life</td>
      <td>First-line chemotherapy by fitness profile, molecularly guided options, palliative integration from early phase</td>
      <td>Treatment goals, toxicity monitoring, trial options, home support logistics</td>
    </tr>
  </tbody>
</table>
<h2>Treatment in 2026: Precision, Sequencing, and Supportive Care</h2>
<p>Therapeutic planning depends on performance status, organ function, comorbid disease, molecular profile, and patient preferences. In fit patients, multi-agent chemotherapy regimens may improve disease control but carry toxicity burdens that require close monitoring. In older or frailer patients, modified dosing or alternative regimens may better balance benefit and safety. There is no universally “best” regimen; good oncology care means individualized sequencing with transparent goals.</p>
<p>For selected molecular subgroups, targeted therapies and biomarker-driven strategies can be relevant, especially in later lines or clinical trial pathways. Although these populations are smaller, testing remains important because actionable findings can change outcomes for specific patients. Equally important is early palliative and supportive care: pain management, nutritional intervention, glycemic control, thrombosis risk management, psychosocial support, and proactive symptom reporting often determine whether patients can continue treatment safely.</p>
<p>Nutrition deserves specific emphasis. Pancreatic cancer can cause anorexia, malabsorption, and rapid muscle loss. Dietitian-guided plans, pancreatic enzyme replacement when indicated, and structured caloric-protein targets can improve resilience during therapy. Families should not underestimate practical preparation: transport, appointment coordination, medication schedules, and emergency contact protocols prevent avoidable treatment interruptions.</p>
<h2>International Patient Checklist: What to Ask Your Team</h2>
<p>To improve decision quality, patients and caregivers can use a short but structured checklist during consultations:</p>
<ul>
  <li>What is the exact stage and resectability category right now?</li>
  <li>Was my case reviewed by a multidisciplinary tumor board?</li>
  <li>Do I need EUS-guided biopsy, repeat imaging, or second pathology review?</li>
  <li>How should CA 19-9 be interpreted in my individual case?</li>
  <li>Should I receive germline and/or somatic molecular testing?</li>
  <li>What is the treatment intent: cure, control, or symptom-focused care?</li>
  <li>What toxicities are most likely, and when should I call urgently?</li>
  <li>Are there clinical trials suitable for my stage and profile?</li>
</ul>
<p>These questions improve clarity, reduce confusion, and support shared decision-making. High-quality cancer care is not passive; informed patients contribute to safer and more consistent care pathways.</p>
<h2>Conclusion</h2>
<p>Pancreatic cancer is serious, but not hopeless. Outcomes improve when warning signs are recognized early, diagnostics are complete, staging is precise, and treatment is coordinated by multidisciplinary teams. For global audiences, the practical priority is clear: do not wait with persistent red-flag symptoms, seek structured oncology evaluation, and insist on evidence-based planning that integrates both survival and quality-of-life goals.</p>
<h2>References</h2>
<ul>
  <li><a href="https://www.who.int/news-room/fact-sheets/detail/cancer">World Health Organization (WHO): Cancer Fact Sheet</a></li>
  <li><a href="https://www.cancer.gov/types/pancreatic">National Cancer Institute: Pancreatic Cancer</a></li>
  <li><a href="https://www.nccn.org/guidelines/category_1">NCCN Clinical Practice Guidelines in Oncology</a></li>
  <li><a href="https://www.asco.org/practice-patients/guidelines">American Society of Clinical Oncology (ASCO) Guidelines</a></li>
  <li><a href="https://www.esmo.org/guidelines/gastrointestinal-cancers/pancreatic-cancer">ESMO Guidelines: Pancreatic Cancer</a></li>
  <li><a href="https://www.iarc.who.int/">International Agency for Research on Cancer (IARC)</a></li>
</ul>`
  },
  {
    title: 'Start Investing in Tokenized Global Stocks and Crypto Gold on Mobile: A Practical Beginner Guide',
    slug: 'start-investing-tokenized-stocks-and-crypto-gold-on-mobile',
    excerpt: 'A practical beginner guide to understanding tokenized stocks and crypto gold from your phone, including first steps, simple strategy, and must-read references.',
    featuredImage: 'https://images.unsplash.com/photo-1611974789855-9c2a0a7236a3?auto=format&fit=crop&w=1200&q=80',
    category: 'Financial Education',
    tags: ['online investing', 'global stocks', 'crypto gold', 'beginners'],
    author: 'Editorial Team',
    publishDate: '2026-03-09',
    updatedDate: '2026-03-09',
    popularScore: 98,
    faq: [
      { q: 'Is mobile investing suitable for beginners?', a: 'Yes, especially when you start small, learn risk basics, and improve your approach gradually.' },
      { q: 'How can I avoid impulsive decisions when starting to invest?', a: 'Set clear goals, automate a fixed monthly amount, avoid FOMO-based choices, and review your strategy regularly.' }
    ],
    content: `## Introduction
Today, investing can start directly from a phone, but beginners still need a clear learning path to make consistent and rational decisions.

## Why It Matters
Tokenized stocks provide global exposure, while crypto gold offers a familiar diversification approach.

## Research Gap
Many investing articles are either too technical or too promotional, so beginners still struggle to move from curiosity to disciplined habits.

## Practical Actions
Start with a small amount, monitor priority assets, use platform education features, and run routine evaluations to keep learning focused.`,
    htmlContent: `<p><em>This article is written to be easy to read, beginner-friendly, and ready for publication with minimal edits.</em></p>
<h2>Introduction</h2>
<p>Financial technology has made investing more accessible than ever. Today, anyone can begin using the device they already use daily: a smartphone. However, easy access alone is not enough. For beginners, the bigger challenge is understanding first steps, managing expectations, and building consistency instead of following short-term hype.</p>
<p>This is why tokenized global stocks and crypto gold are relevant topics. They bridge digital innovation with assets that are easier to understand. Stocks represent growth potential, while gold is often associated with portfolio stability and diversification.</p>
<figure>
  <img src="https://images.unsplash.com/photo-1563013544-824ae1b704d3?auto=format&fit=crop&w=1200&q=80" alt="Online investing illustration on a smartphone" loading="lazy" />
  <figcaption>Figure 1. Digital investments can now be monitored directly from a smartphone.</figcaption>
</figure>
<h2>Review: Better Access Must Be Matched by Better User Experience</h2>
<p>The key shift in digital investing is moving from simple access to quality experience. A strong platform should not only enable transactions, but also help users understand what they are buying, why it fits their goal, and how to manage risk proportionally.</p>
<p>For beginners, the early experience is critical. Most do not need complex strategies yet. They need a realistic structure: observe the market, learn key terms, test with a small amount, and build repeatable habits.</p>
<h2>Research Gap: Plenty of Content, Limited Step-by-Step Guidance</h2>
<p>Many investment contents sit at two extremes: too technical or too promotional. As a result, beginners may understand product definitions but still feel unsure when making their first small decision.</p>
<p>What beginners need most is an actionable sequence: understand the product, map the risk, test a small amount, and evaluate consistently.</p>
<figure>
  <img src="https://images.unsplash.com/photo-1554224155-6726b3ff858f?auto=format&fit=crop&w=1200&q=80" alt="Investment learning flow from registration to monitoring" loading="lazy" />
  <figcaption>Figure 2. Beginner investing flow: registration, exploration, education, and routine monitoring.</figcaption>
</figure>
<h2>Practical Application: From Observation to Habit</h2>
<p>A healthy starting point for beginners is simple observation. You can monitor <a href="https://pintu.co.id/market/nvdax">NVIDIA tokenized stock price</a> to understand global technology-related asset movement.</p>
<p>For diversification with digital gold, observe <a href="https://pintu.co.id/market/paxg">PAXG price</a> and learn where it fits in a simple allocation strategy.</p>
<p>If you want a practical starting path, this <a href="https://pintu.co.id/aplikasi-investasi-emas-crypto">buy gold page</a> can help you understand the product journey.</p>
<p>From a security perspective, this reference about a <a href="https://pintu.co.id/aplikasi-crypto-aman">secure crypto app</a> is useful before allocating funds.</p>
<p>These paths can be explored through <a href="https://pintu.co.id">Pintu</a> as an integrated market, education, and asset-monitoring ecosystem.</p>
<h2>Conclusion</h2>
<p>Digital investing opens broader opportunities for participation. Long-term outcomes, however, are shaped by learning quality and consistent behavior. By starting small, learning continuously, and using platforms that support education, beginners can build healthier and more sustainable investment habits.</p>`
  },
  {
    title: 'Dizziness and Nausea: When Is It Normal and When Should You See a Doctor?',
    slug: 'dizziness-and-nausea-when-to-see-a-doctor',
    excerpt: 'A practical guide to common causes of dizziness with nausea, safe first steps at home, and warning signs.',
    featuredImage: 'https://images.unsplash.com/photo-1579154204601-01588f351e67?auto=format&fit=crop&w=1200&q=80',
    category: 'Common Symptoms',
    tags: ['dizziness', 'nausea', 'common symptoms'],
    author: 'dr. Sobri Editorial Team',
    publishDate: '2026-03-01',
    updatedDate: '2026-03-05',
    popularScore: 89,
    faq: [
      { q: 'Is dizziness always a sign of serious disease?', a: 'No. Many cases are linked to fatigue, dehydration, or delayed meals, but recurrent symptoms should still be evaluated.' },
      { q: 'When should I go to the ER?', a: 'If dizziness appears with slurred speech, one-sided weakness, chest pain, or decreased consciousness.' }
    ],
    content: `## Summary\nDizziness and nausea are common complaints. Many causes are mild, but some conditions need urgent evaluation.\n\n## First steps\n- Get adequate rest\n- Drink enough water\n- Avoid standing up suddenly\n\n## When to see a doctor\nIf symptoms persist for more than 24 hours, happen repeatedly, or appear with danger signs.`
  },
  {
    title: "How to Reduce a Child's Fever Safely at Home",
    slug: 'how-to-reduce-child-fever-safely-at-home',
    excerpt: 'A practical parent guide for managing fever at home, including hydration, temperature monitoring, and referral signs.',
    featuredImage: 'https://images.unsplash.com/photo-1600959907703-c1f3e0d5b6f9?auto=format&fit=crop&w=1200&q=80',
    category: 'Family Health',
    tags: ['child fever', 'parenting', 'family health'],
    author: 'dr. Sobri Editorial Team',
    publishDate: '2026-02-27',
    updatedDate: '2026-03-02',
    popularScore: 95,
    faq: [{ q: 'At what temperature should a child see a doctor?', a: 'Usually above 39°C, if the child is lethargic, refuses fluids, or has seizures.' }],
    content: `## What is fever\nFever is the body's response to infection. The main focus is keeping the child comfortable and preventing dehydration.`
  },
  {
    title: 'Myth vs Fact: Does Drinking Ice-Cold Water Cause Flu?',
    slug: 'myth-vs-fact-does-ice-water-cause-flu',
    excerpt: 'Clarifying a common misconception about cold drinks and flu in simple language for general readers.',
    featuredImage: 'https://images.unsplash.com/photo-1523362628745-0c100150b504?auto=format&fit=crop&w=1200&q=80',
    category: 'Myth vs Fact',
    tags: ['flu', 'health myths'],
    author: 'dr. Sobri Editorial Team',
    publishDate: '2026-02-20',
    updatedDate: '2026-02-21',
    popularScore: 80,
    faq: [{ q: 'What causes flu?', a: 'Flu is caused by the influenza virus, not by drink temperature.' }],
    content: `## Key fact\nFlu is caused by viral infection. Cold drinks may cause discomfort in some people, but they are not a direct cause of flu.`
  },
  ...generatedOncologyArticles
];
